logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Almaject, Inc. drugs

    FiltersReset Filters
    8 results

    • acetylcysteine

      (Acetylcysteine)
      Almaject, Inc.

    • dexrazoxane

      (Dexrazoxane for Injection)
      Almaject, Inc.
      Usage: Dexrazoxane for Injection is indicated to reduce cardiomyopathy incidence and severity in women with metastatic breast cancer receiving doxorubicin, after a cumulative dose of 300 mg/m², who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin treatment.

    • dexrazoxane

      (Dexrazoxane for Injection)
      Almaject, Inc.
      Usage: Dexrazoxane for Injection is indicated to reduce the incidence and severity of cardiomyopathy in women with metastatic breast cancer receiving cumulative doxorubicin doses of 300 mg/m² or more, who will continue doxorubicin therapy for tumor control. It should not be used at the start of doxorubicin therapy.

    • metoprolol tartrate - metoprolol tartrate injection, solution

      (Metoprolol Tartrate)
      Almaject, Inc.

    • midazolam - midazolam injection, solution

      (Midazolam)
      Almaject, Inc.

    • midazolam - midazolam injection, solution

      (Midazolam)
      Almaject, Inc.

    • regadenoson

      (Regadenoson)
      Almaject, Inc.
      Usage: Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress testing.

    • temsirolimus

      (Temsirolimus Injection)
      Almaject, Inc.
      Usage: Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma.